Andreas Serra

Prof. Dr. Andreas Serra is a faculty member at the Department of Internal Medicine and Nephrology, Klinik Hirslanden, Zurich, and affiliated with the Epidemiology, Biostatistics and Prevention Institute (EBPI) at the University of Zurich. His research focuses on the mammalian target of rapamycin (mTOR) signaling pathway and therapeutic strategies for autosomal dominant polycystic kidney disease (ADPKD) and tuberous sclerosis complex (TSC).

• Education: MD, MPH
• Institutions: University of Bern, University of Alabama in Birmingham, Harvard University

Prof. Serra leads the SUISSE ADPKD cohort and co-directs the Swiss TSC network, emphasizing translational research in inherited kidney diseases and related genetic disorders. His work bridges clinical nephrology, molecular signaling pathways, and epidemiological studies.